The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A multi-institution study of the accuracy of BRCAPRO in predicting BRCA1/BRCA2 mutations in women with ovarian cancer.
Molly S Daniels
No relevant relationships to disclose
Sheri Babb
No relevant relationships to disclose
Robin King
No relevant relationships to disclose
Diana Urbauer
No relevant relationships to disclose
Christopher I. Amos
No relevant relationships to disclose
Amanda C. Brandt
No relevant relationships to disclose
Adam Buchanan
No relevant relationships to disclose
David Gardner Mutch
No relevant relationships to disclose
Karen H. Lu
No relevant relationships to disclose